Article Details

Roche's eye drug Faricimab meets primary endpoint

Retrieved on: 2021-01-25 06:33:45

Tags for this article:

Click the tags to see associated articles and topics

Roche's eye drug Faricimab meets primary endpoint. View article details on hiswai:

Excerpt

Roche Holding AG said Monday that its eye treatment Faricimab met its primary endpoint in two phase 3 studies. The Swiss pharmaceutical major said ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up